PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α. (June 2017) - Berinstein, N.; Smyth, L.; Pennell, N.; Weerasinghe, R.; Cheung, M.; Imrie, K.; Spaner, D.; Chodirker, L.; Piliotis, E.; Milliken, V.; Boudreau, A.; Zhang, L.; et al.